Related Experiment Video
Updated: Aug 10, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
Botulinum toxin A relieved neuropathic pain in a case of post-herpetic neuralgia
Hsu-Tang Liu1, Shen-Kou Tsai, Ming-Chang Kao
1Department of Anesthesiology, Taipei Veterans General Hospital, Taipei, Taiwan.
Abstract:
Botulinum toxin type A (BTX-A) has been widely used in many clinical disorders including migraine, cervical dystonia, etc. The use of BTX-A in neuropathic pain, however, is uncommon, and the application of the anti-nociceptive effect of botulinum toxin is emerging. Here we report a case of an 80-year-old man who suffered from severe pain of post-herpetic neuralgia which was refractory to the usual therapies. However, this neuropathic pain was dramatically relieved by multiple BTX-A injection and the pain relief lasted 52 days.
Related Concept Videos
Chickenpox
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Botulism
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Skeletal Muscle Relaxants: Therapeutic Uses

